肺康复改善肺栓塞后患者体能、呼吸困难与生活质量:PeRehab随机对照试验方案
本研究为挪威两中心随机对照试验(RCT),针对肺栓塞后综合征(PPS)患者,比较监督下门诊肺康复项目(每周2次、每次1小时、共8周)与常规护理的效果。主要结局为增量穿梭步行试验,并评估耐力、日常活动、呼吸困难及健康相关生活质量,计划招募190例患者。
要点
- PPS患者表现为持续性呼吸困难、体能差和生活质量下降,是肺康复的潜在适宜人群。
- 干预为每周2次、每次1小时、共8周的监督下门诊肺康复,含个体化运动和教育课程。
- 主要结局为增量穿梭步行试验,评估时间点为基线、12周和36周。
核心结论
- 该研究旨在探索肺康复能否改善PPS患者的体能、呼吸困难和生活质量。
- 结果可能为这一目前缺乏有效治疗的PPS群体提供干预依据。
研究设计与样本
- 两中心随机对照试验(RCT),在挪威Østfold医院和Akershus大学医院进行。
- PPS患者按1:1随机分为干预组或对照组,计划招募190例患者。
- 干预组接受每周2次、每次1小时、共8周的监督下门诊康复,由经验丰富的物理治疗师提供。
- 干预包括基于现有肺康复项目的个体化运动(放松、间歇和抗阻训练)及一次教育课程。
- 对照组接受常规护理,不给予具体运动指导。
主要发现
- 原文未报告试验结果,仅描述研究方案。
关键数值与推荐
- 主要结局为增量穿梭步行试验,在基线、12周和36周评估。
- 次要结局包括耐力穿梭步行试验、Sensewear活动监测仪、改良医学研究委员会量表、呼吸困难问卷、EQ-5D-5L和肺栓塞生活质量问卷。
- 试验注册号NCT03405480,于2017年9月前瞻性注册。
临床怎么用
- 原文未提供临床实践推荐,仅描述研究方案。
局限性
- 原文未报告研究的局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Recently, a large group of patients with persistent dyspnea, poor physical capacity, and reduced health-related quality of life (HRQoL) following pulmonary embolism (PE) has been identified and clustered under the name "post pulmonary embolism syndrome" (PPS). These patients seem good candidates for pulmonary rehabilitation. The aim of the study is to explore whether a pulmonary rehabilitation program can improve physical capacity, dyspnea, and HRQoL in PPS patients. METHODS: A two-center randomized controlled trial (RCT) is being performed at Østfold Hospital and Akershus University Hospital in Norway. Patients with PPS are 1:1 randomized into an intervention or a control group. The intervention consists of a supervised, outpatient rehabilitation program twice weekly (1 h) for 8 weeks provided by experienced physiotherapists. The intervention involves individually adapted exercises based on existing pulmonary rehabilitation programs (relaxation, interval, and resistance training), and an educational session including topics such as normal anatomy and physiology of the respiratory and circulatory system, information on PE/PPS, breathing strategies, and benefits of exercise/physical activity. Patients randomized to the control group receive usual care without specific instructions to exercise. Participants in the intervention and control groups will be compared based on assessments conducted at baseline, 12 weeks, and 36 weeks after inclusion using the incremental shuttle walk test (primary outcome) and endurance shuttle walk test (exercise capacity), Sensewear activity monitor (daily physical activity), the modified Medical Research Council scale, the Shortness of Breath Questionnaire (dyspnea), and EQ-5D-5L and the Pulmonary Embolism Quality of Life Questionnaire (HRQoL). Recruitment of 190 patients is currently ongoing. DISCUSSION: Results from this study may provide a currently untreated group of PPS patients with an effective treatment resulting in reduced symptoms of dyspnea, improved exercise capacity, and better HRQoL following PE. TRIAL REGISTRATION: Clinical Trials NCT03405480 . Registered prospectively on September 2017. Protocol version 1 (from original protocol September 2017). The study protocol has been reported in accordance with the Standard Protocol Items: Recommendations for Clinical Interventional Trials (SPIRIT) guidelines (Additional file 1).
引用
- Haukeland-Parker S, Jervan Ø, Johannessen HH, et al. Pulmonary rehabilitation to improve physical capacity, dyspnea, and quality of life following pulmonary embolism (the PeRehab study): study protocol for a two-center randomized controlled trial. Trials. 2021. PMID: 33407792. doi:10.1186/s13063-020-04940-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。